Ad is loading...
MIQBX
Price
$13.89
Change
-$0.11 (-0.79%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

MIQBX vs VTSNX

Header iconMIQBX vs VTSNX Comparison
Open Charts MIQBX vs VTSNXBanner chart's image
Morgan Stanley Inst International Eq A
Price$13.89
Change-$0.11 (-0.79%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
MIQBX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MIQBX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIQBX is a StrongSell and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. MIQBX (776M). VTSNX pays higher dividends than MIQBX: VTSNX (3.29) vs MIQBX (0.29). MIQBX was incepted earlier than VTSNX: MIQBX (29 years) vs VTSNX (14 years). MIQBX is a more actively managed with annual turnover of: 28.00 vs. VTSNX (4.00). MIQBX has a lower initial minimum investment than VTSNX: MIQBX (1000) vs VTSNX (5000000). VTSNX annual gain was more profitable for investors over the last year : 10.92 vs. MIQBX (6.43). VTSNX return over 5 years is better than : 15.91 vs. MIQBX (-6.37).
MIQBXVTSNXMIQBX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence29 years14 years-
Gain YTD1.2394.53527%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets776M442B0%
Annual Yield % from dividends0.293.299%
Returns for 1 year6.4310.9259%
Returns for 3 years-15.90-5.86271%
Returns for 5 years-6.3715.91-40%
Returns for 10 years-7.7929.81-26%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals